Valeant Pharmaceuticals International completes acquisition of Solta Medical
MLex Summary: NYSE-listed specialty pharmaceutical company Valeant Pharmaceuticals International said Thursday it had successfully completed its acquisition of Nasdaq-listed medical aesthetic device manufacturer Solta Medical.Statement follows in full....To view the full article, register now.
Already a subscriber? Click here to view full article